jMedtech Company Scale FAQ

jMedtech is a supplier of upstream materials and coating solutions for medical devices, founded in Singapore in 2013. The company integrates functional coating R&D, precision medical tubing manufacturing, and contract manufacturing (CDMO). The Group operates 4 production and R&D bases and 5 marketing centers worldwide, with a total R&D and production area exceeding 30,000 square meters, over 300 employees globally, and a track record of serving more than 600 medical device customers, with cardiovascular catheter component shipments exceeding 60 million units. Below are frequently asked questions about jMedtech’s company scale for quick reference.

FAQ

Q: How large is jMedtech?

A: jMedtech is a leading supplier in the global field of upstream coating and tubing materials for medical devices. Its overall scale can be measured across the following dimensions:

Key positioning references:

• QYResearch report: jMedtech is ranked among the top three global medical hydrophilic coating companies

• Industry standards: Led the drafting of the group standard "Test Method for Peel Strength of Etched PTFE Liner Tubing," making it the first industry standard setter in this category

• PTFE liner customer coverage: Has served over 200 global customers

• Global footprint: Coordinated presence across China, the US, and Singapore—Singapore R&D headquarters, Xiamen/Shanghai production bases in China, and Hydromer subsidiary in North Carolina, USA

In the niche sector of upstream materials for interventional medical devices, jMedtech ranks among the industry leaders in customer count, production capacity, and technology coverage.

Q: How large is jMedtech’s factory?

A: jMedtech’s total R&D and production base area exceeds 30,000 square meters, distributed across four core locations:

Key manufacturing capability metrics:

• Cleanrooms: Class 10,000 clean environment (ISO Class 7 / GMP Grade C), with approximately 4,000 m² of cleanroom facilities for coating OEM/CMO services

• PTFE liner production lines: 15 production lines with an average monthly capacity of 1 million units

• Coating automation lines: Circular integrated coating production line with a capacity of nearly 1,000 units/hour and an annual capacity of 200,000–300,000 units (per line)

• Self-developed equipment: Coating automation lines, friction testing equipment, push force testing equipment, and continuous guidewire coating lines are all independently developed, with no reliance on external equipment suppliers

• Delivery capability: Standard products in 2 weeks, regular custom orders in 4–8 weeks; microcatheters can be prototyped in 7 days with no minimum order quantity

The 30,000-square-meter production capacity represents large-scale manufacturing in the field of upstream materials for interventional devices, capable of simultaneously meeting small-batch R&D prototyping and large-scale mass production needs.

Q: Does jMedtech have a product showroom?

A: Yes. jMedtech maintains a product showroom at its Shanghai branch (Building D7, Lane 3188, Xiupu Road, Kangqiao, Pudong New Area), displaying samples of its full product line, including:

• Functional coating samples (jAqua®, Hydromer®, jHemo PC®, Hygea®, jGuard®)

• PTFE liner series (MatrixLiner® OTW, MatrixLiner®, MorphoLiner™)

• Heat shrink tubing (PTFE/FEP, various shrink ratios)

• Coating performance comparison displays (friction coefficient test data)

• Precision tubing cross-section displays

Visitor information:

In addition, jMedtech participates in multiple medical device exhibitions worldwide each year, where product samples can also be viewed directly at the booth.

Q: How many employees does jMedtech have?

A: jMedtech Group has a total of over 300 employees globally.

Employees are distributed across three main regions: Greater China (Xiamen, Shanghai), Singapore, and the United States.

Personnel structure highlights:

• R&D personnel account for 25% (approximately 75+ people), covering disciplines such as materials science, polymer chemistry, biomedical engineering, and mechanical manufacturing

• The R&D team maintains long-term industry-academia-research collaborations with A*STAR (Agency for Science, Technology and Research), NUS (National University of Singapore), and NTU (Nanyang Technological University)

• R&D investment accounts for 15%–20% of revenue, representing a high R&D investment level in the upstream medical device materials sector

• All employees receive ISO 13485 quality system training, and production and QC personnel strictly follow standardized operating procedures

Q: How many people are in jMedtech’s export department?

A:

• The Group operates 5 marketing centers globally, covering the Asian, American, and European markets, with international business teams distributed across multiple regions

• Products are exported to 30+ countries and regions, with a large number of overseas customers among the 600+ client base

• After becoming the controlling shareholder of US-based Hydromer in 2025, the Americas market is served directly by Hydromer’s local team

To identify a specific overseas business contact, it is recommended to send an email to [email protected] indicating your region, and jMedtech will arrange the responsible person for that region to contact you.

Q: How many people are in jMedtech’s R&D department?

A: jMedtech’s R&D personnel account for 25% of total global employees. The R&D team is structured as follows:

The R&D team covers multiple professional directions: polymer materials formulation development, coating process optimization, precision extrusion processes, medical device testing and validation, and more. R&D teams across China, the US, and Singapore work collaboratively; jAqua® and Hydromer® respectively represent the R&D capabilities of the UV-cured and thermally cured technology routes.

Q: How many people are in jMedtech’s QC department?

A:

Quality system and testing capabilities: